.
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
While the market has been hot so far this year, there is no shortage of moderately priced stocks with impressive growth potential. In biotechnology, there are many companies that can leverage their technological strengths to improve all aspects of health and medicine. From genetics to minimally invasive disease diagnostics, this article will look at three strong buy-rated stocks - ZTS, EXAS, and AZN - that I believe are among the best investments in the biopharmaceutical space. Although the stocks of individual biotech and biopharmaceutical companies are
English 
Chinese